Severity-Standardized ALOS - Special Care
-
Standardized ALOS for special inpatient care (i.e., care provided in intensive care units).
CBE ID0332
Standardized ALOS for special inpatient care (i.e., care provided in intensive care units).
Standardized average length of hospital stay (ALOS) for routine inpatient care (i.e., care provided outside of intensive care units).
The SNFRM estimates the risk-standardized rate of all-cause, unplanned hospital readmissions for Skilled Nursing Facility (SNF) Medicare fee-for-service (FFS) beneficiaries within 30 days of discharge from a prior proximal acute hospitalization. The prior proximal hospitalization is defined as an admission to an IPPS, CAH, psychiatric, or cancer hospital. The measure is risk-adjusted for patient demographics, principal diagnosis from the prior hospitalization, comorbidities, and other health status variables that affect the probability of a hospital readmission.
Ratio of observed to expected major adverse events (MAE) among patients undergoing congenital cardiac catheterization, risk-adjusted using the Catheterization for Congenital Heart Disease Adjustment for Risk Method II (CHARM II).
This measure is a ratio of observed to expected rate of in-hospital mortality following non-cardiac surgery among infants <= 30 days of age, risk-adjusted.
The Standardized Readmission Ratio (SRR) for a dialysis facility is the ratio of the number of observed index discharges from acute care hospitals to that facility that resulted in an unplanned readmission to an acute care hospital within 4-30 days of discharge to the expected number of readmissions given the discharging hospitals and the characteristics of the patients and based on a national norm. Note that the measure is based on Medicare-covered dialysis patients.
Percent of acute myocardial infarction (AMI) patients who are prescribed a statin at hospital discharge.
The percentage of patients ages 40 to 75 years who were dispensed a medication for diabetes that receive a statin medication.
This measure identifies patients undergoing percutaneous coronary intervention (PCI) with placement of a drug-eluting intracoronary stent during the first 9 months of the measurement year, who filled a prescription for clopidogrel in the 3 months following stent placement.
The percentage of patients aged 18 years and older who have been on chronic steroids for at least 180 days and had a bone density evaluation or were taking osteoporosis treatment